NPPA issued a notification regarding fixation of the retail price of Olanzapine IP 5 mg + Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Cadila Pharmaceuticals Limited (Marketer)

Apr 07, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on April 06, 2026, issued a notification regarding the fixation of the retail price of Olanzapine IP 5 mg + Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Cadila Pharmaceuticals Limited (Marketer).

The following has been stated: -

•For each Film-coated tablet containing Olanzapine IP 5 mg + Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg for M/s Windlas Biotech Limited (Manufacturer) & M/s Cadila Pharmaceuticals Limited (Marketer), the retail price is 10.64 (Rs).

The detailed notification is given in the document below.

[Notification No.: 19(5078)/2026/DP/NPPA/Div.III/13524/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT